Zou Y, Li H, Graham ET, et al. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol. 2020;16(3):302-309. doi:10.1038/s41589-020-0472-6
Metabolomics Platform
Balasubramanian R, Paynter NP, Giulianini F, et al. Metabolomic profiles associated with all-cause mortality in the Women’s Health Initiative. Int J Epidemiol. 2020;49(1):289-300. doi:10.1093/ije/dyz211
Fornelos N, Franzosa EA, Bishai J, et al. Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease. Nat Microbiol. 2020. doi:10.1038/s41564-019-0655-7
Chandler PD, Balasubramanian R, Paynter N, et al. Metabolic signatures associated with Western and Prudent dietary patterns in women. The American journal of clinical nutrition. 2020;112(2):268-283. doi:10.1093/ajcn/nqaa131
Papandreou C, Hernández-Alonso P, Bulló M, et al. High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study. The Journal of nutrition. 2020;150(11):2882-2889. doi:10.1093/jn/nxaa273
Xu YX, Peloso GM, Nagai TH, et al. EDEM3 Modulates Plasma Triglyceride Level through Its Regulation of LRP1 Expression. iScience. 2020;23(4):100973. doi:10.1016/j.isci.2020.100973
Hong X, Zhang B, Liang L, et al. Postpartum plasma metabolomic profile among women with preeclampsia and preterm delivery: implications for long-term health. BMC medicine. 2020;18(1):277. doi:10.1186/s12916-020-01741-4
Quinn RA, Melnik A V, Vrbanac A, et al. Global chemical effects of the microbiome include new bile-acid conjugations. Nature. 2020;579(7797):123-129. doi:10.1038/s41586-020-2047-9
Li X, Li Z, Zhou H, et al. Dynamic incorporation of multiple in silico functional annotations empowers rare variant association analysis of large whole-genome sequencing studies at scale. Nature genetics. 2020;52(9):969-983. doi:10.1038/s41588-020-0676-4
Molsberry S, Bjornevik K, Hughes KC, et al. Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson’s Disease. Journal of Parkinson’s disease. 2020;10(3):1011-1021. doi:10.3233/JPD-191896